Pentraxins, anti-pentraxin antibodies, and atherosclerosis (Q37328097)

19 August 2017

1 reference

title

Pentraxins, anti-pentraxin antibodies, and atherosclerosis (English)

1 reference

19 August 2017

1 reference

1 reference

7

A Doria

1 reference

19 August 2017

N Bassi

1

1 reference

19 August 2017

S Zampieri

2

1 reference

19 August 2017

A Ghirardello

3

1 reference

19 August 2017

M Tonon

4

1 reference

19 August 2017

M Zen

5

1 reference

19 August 2017

F Cozzi

6

1 reference

19 August 2017

1 August 2009

1 reference

Clinical Reviews in Allergy & Immunology

19 August 2017

1 reference

19 August 2017

37

1 reference

19 August 2017

1

1 reference

19 August 2017

36-43

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-008-8098-6

19 August 2017

0 references

cites work

The Th17/Treg imbalance in patients with acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12016-008-8098-6

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-008-8098-6

Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-008-8098-6

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-008-8098-6

Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-008-8098-6

PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-008-8098-6

Perturbation of the T-Cell Repertoire in Patients With Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-008-8098-6

Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia

21 January 2018

1 reference

12 December 2020

The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation

1 reference

12 December 2020

Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages.

1 reference

12 December 2020

The immune response in atherosclerosis: a double-edged sword

1 reference

12 December 2020

The interaction of C-reactive protein and serum amyloid P component with nuclear antigens

1 reference

12 December 2020

Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure

1 reference

12 December 2020

Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjögren's syndrome, rheumatoid arthritis or inflammatory bowel disease

1 reference

12 December 2020

Atherosclerosis in patients with autoimmune disorders

1 reference

12 December 2020

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.

1 reference

12 December 2020

Role of antiheat shock protein 60 autoantibodies in atherosclerosis

1 reference

12 December 2020

C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo

1 reference

12 December 2020

C-reactive protein binds to the 3beta-OH group of cholesterol in LDL particles

1 reference

12 December 2020

Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component

1 reference

12 December 2020

The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis

1 reference

12 December 2020

Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation

1 reference

12 December 2020

Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients

1 reference

12 December 2020

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis

1 reference

12 December 2020

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

1 reference

12 December 2020

Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells

1 reference

12 December 2020

FcgammaRIIa mediates C-reactive protein-induced inflammatory responses of human vascular smooth muscle cells by activating NADPH oxidase 4.

1 reference

12 December 2020

Vaccinia virus complement control protein diminishes formation of atherosclerotic lesions: complement is centrally involved in atherosclerotic disease

1 reference

12 December 2020

Autoimmunity to protective molecules: is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic diseases?

1 reference

12 December 2020

Prevalence and pathology of amyloid in atherosclerotic arteries

1 reference

12 December 2020

Non-fibrillar components of amyloid deposits mediate the self-association and tangling of amyloid fibrils.

1 reference

12 December 2020

Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.

1 reference

12 December 2020

Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence

1 reference

12 December 2020

The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages

1 reference

12 December 2020

Serum amyloid P component and cardiovascular disease: is there a sensible link?

1 reference

12 December 2020

Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats

1 reference

12 December 2020

C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity

1 reference

12 December 2020

Atherosclerosis and autoimmunity

1 reference

12 December 2020

Accelerated atherosclerosis in autoimmune rheumatic diseases

1 reference

12 December 2020

A systematic study of the effect of physiological factors on beta2-microglobulin amyloid formation at neutral pH.

1 reference

12 December 2020

Aggregated IgG inhibits the differentiation of human fibrocytes.

1 reference

12 December 2020

Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study.

1 reference

12 December 2020

Production of the long pentraxin PTX3 in advanced atherosclerotic plaques

1 reference

12 December 2020

Artherosclerosis as an infectious, inflammatory and autoimmune disease

1 reference

12 December 2020

Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages

1 reference

12 December 2020

The antimicrobial activity of C-reactive protein

1 reference

12 December 2020

CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation

1 reference

12 December 2020

Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity

1 reference

12 December 2020

Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity

1 reference

12 December 2020

Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies

1 reference

12 December 2020

OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients

1 reference

12 December 2020

Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions.

1 reference

12 December 2020

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

1 reference

12 December 2020

Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study

1 reference

12 December 2020

Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial

1 reference

12 December 2020

Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Inflammation, atherosclerosis, and coronary artery disease

1 reference

12 December 2020

Inflammation and accelerated atherosclerosis: basic mechanisms

1 reference

12 December 2020

Specific cellular features of atheroma associated with development of neointima after carotid endarterectomy: the carotid atherosclerosis and restenosis study

1 reference

12 December 2020

Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients

1 reference

12 December 2020

Human serum amyloid P component is a single uncomplexed pentamer in whole serum

1 reference

12 December 2020

Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits

1 reference

12 December 2020

Autoimmunity in atherosclerosis: a protective response losing control?

1 reference

12 December 2020

Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells

1 reference

12 December 2020

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

12 December 2020

C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling

1 reference

12 December 2020

Coronary C-reactive protein distribution: its relation to development of atherosclerosis

1 reference

12 December 2020

Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation

1 reference

12 December 2020

Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.

1 reference

12 December 2020

Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells

1 reference

12 December 2020

Chemokines and cardiovascular risk

1 reference

12 December 2020

Complement-endothelial cell interactions: pathophysiological implications.

1 reference

12 December 2020

The long pentraxin 3 and its role in autoimmunity

1 reference

12 December 2020

The physiological structure of human C-reactive protein and its complex with phosphocholine

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction

1 reference

12 December 2020

Molecular mechanisms regulating Th1 immune responses

1 reference

12 December 2020

Epitopes on beta2-GPI recognized by anticardiolipin antibodies

1 reference

12 December 2020

Inflammation and atherosclerosis

1 reference

12 December 2020

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

1 reference

12 December 2020

Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain

1 reference

12 December 2020

Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome

1 reference

12 December 2020

Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity

1 reference

12 December 2020

C-reactive protein, anti-C-reactive protein antibodies and clinical atherosclerosis

1 reference

12 December 2020

Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.

1 reference

12 December 2020

Pentraxins, humoral innate immunity and tissue injury

1 reference

12 December 2020

Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or von Willebrand factor to newly expressed cell surface GPIIb-IIIa

1 reference

12 December 2020

Regulatory T-cell immunity and its relevance to atherosclerosis

1 reference

12 December 2020

Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen

1 reference

12 December 2020

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice

1 reference

12 December 2020

IL-1 and IL-6 mediate increased production and synthesis by hepatocytes of acute-phase reactant mouse serum amyloid P-component (SAP)

1 reference

12 December 2020

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

1 reference

12 December 2020

Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility

1 reference

12 December 2020

10.1007/S12016-008-8098-6

Identifiers

DOI

1 reference

19 August 2017

1 reference